Ridgewood Investments’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-34,449
Closed -$107K 610
2025
Q2
$107K Sell
34,449
-6,161
-15% -$18.4K 0.05% 249
2025
Q1
$135K Buy
40,610
+38,610
+1,931% +$136K 0.06% 216
2024
Q4
$6.14K Buy
+2,000
New +$6.81K ﹤0.01% 555

Other funds holding SOPH

Ridgewood Investments's SOPH Position: Q3 2025 in Review

Ridgewood Investments sold out of SOPHiA GENETICS (SOPH) in Q3 2025, closing a stake of 34,449 shares — an estimated $107K sold.

Ridgewood Investments first reported a position in SOPH in Q4 2024 and held it in 3 quarters. The position peaked at $135K in Q1 2025. 40 funds tracked by Wall St. Rank hold SOPH as of Q3 2025.

  • Ridgewood Investments reported no remaining SOPHiA GENETICS position as of Q3 2025 after selling out during the quarter.
  • Ridgewood Investments sold 34,449 SOPHiA GENETICS shares in Q3 2025, an estimated $107K.
  • Ridgewood Investments first reported a position in SOPHiA GENETICS in Q4 2024 and held it in 3 quarters.
  • Ridgewood Investments's SOPHiA GENETICS position peaked at $135K in Q1 2025.
  • 40 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2025.

Based on Ridgewood Investments's 13F filing for Q3 2025, filed 30 Oct 2025.